We are currently upgrading our website. Please bear with us if you are experiencing any loading issues.

There are 10 reasons why we're excited for 2024.

Home » Newsletter 2024 » Addressing Access Barriers for Diagnostics

Addressing Access Barriers for Diagnostics

APACMed’s In-Vitro Diagnostics working group will continue to work on bringing together different stakeholders within healthcare to raise awareness on the value of diagnostics.

Three key pillars:

  • Generate awareness around the need for adequate investment on improving diagnostic capacity in APAC leveraging the landmark World Health Assembly (WHA) Resolution’s (particularly Essential Diagnostics List) implementation.
  • Advocate for adoption of fit-for-purpose value assessment framework (VAF) for Diagnostic funding and reimbursement in APAC.
  • Unlocking the value of innovative technologies such as Precision Medicine through Next Generation Sequencing.
Shopping Basket